"Follow-Up Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Descriptor ID |
D005500
|
MeSH Number(s) |
E05.318.760.500.750.249 N05.715.360.775.175.250.350 N06.850.520.450.500.750.350
|
Concept/Terms |
Follow-Up Studies- Follow-Up Studies
- Follow Up Studies
- Follow-Up Study
- Studies, Follow-Up
- Study, Follow-Up
- Followup Studies
- Followup Study
- Studies, Followup
- Study, Followup
|
Below are MeSH descriptors whose meaning is more general than "Follow-Up Studies".
Below are MeSH descriptors whose meaning is more specific than "Follow-Up Studies".
This graph shows the total number of publications written about "Follow-Up Studies" by people in this website by year, and whether "Follow-Up Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 42 | 42 |
1995 | 0 | 59 | 59 |
1996 | 0 | 45 | 45 |
1997 | 0 | 58 | 58 |
1998 | 0 | 51 | 51 |
1999 | 0 | 59 | 59 |
2000 | 0 | 60 | 60 |
2001 | 0 | 68 | 68 |
2002 | 0 | 61 | 61 |
2003 | 0 | 53 | 53 |
2004 | 0 | 54 | 54 |
2005 | 0 | 58 | 58 |
2006 | 0 | 106 | 106 |
2007 | 0 | 96 | 96 |
2008 | 0 | 98 | 98 |
2009 | 0 | 79 | 79 |
2010 | 0 | 73 | 73 |
2011 | 0 | 120 | 120 |
2012 | 0 | 118 | 118 |
2013 | 0 | 114 | 114 |
2014 | 0 | 132 | 132 |
2015 | 0 | 131 | 131 |
2016 | 0 | 114 | 114 |
2017 | 1 | 114 | 115 |
2018 | 0 | 138 | 138 |
2019 | 0 | 146 | 146 |
2020 | 0 | 111 | 111 |
2021 | 0 | 75 | 75 |
2022 | 0 | 29 | 29 |
2023 | 0 | 22 | 22 |
2024 | 0 | 46 | 46 |
To return to the timeline,
click here.
Below are the most recent publications written about "Follow-Up Studies" by people in Profiles.
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
-
CT-Based Lung Size Matching in Delayed Chest Closure for Systemic Sclerosis Lung Transplantation. Clin Transplant. 2024 Dec; 38(12):e70041.
-
Influence of Acuity Circles on Hepatocellular Carcinoma and the Interaction of Gender and Race in Liver Transplantation. Clin Transplant. 2024 Dec; 38(12):e70045.
-
Factors affecting Family Physician follow-up 30 days post-discharge from a Canadian Academic Emergency Department. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
-
Utilization of the Liver-First Approach in Combined Lung-Liver Transplant Provides Comparable Outcomes to the Traditional Lung-First Approach: A UNOS Study. Clin Transplant. 2024 Nov; 38(11):e70003.
-
Veno-Venous Extracorporeal Membrane Oxygenation Support for Severe Primary Graft Dysfunction Is Associated With Reduced Airway Complications After Lung Transplantation. Clin Transplant. 2024 Nov; 38(11):e70029.
-
Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence. J Clin Endocrinol Metab. 2024 Oct 15; 109(11):2729-2734.
-
The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma. Surg Oncol. 2024 Dec; 57:102156.
-
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer. Ann Surg Oncol. 2024 Dec; 31(13):8829-8842.
-
Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension. J Pediatr Ophthalmol Strabismus. 2024 Nov-Dec; 61(6):434-441.